Flurbiprofen on Lux 5µm Amylose-1 by SFC
LC Conditions
Column
Lux 5 µm Amylose-1, LC Column 250 x 4.6 mm, EA
Brand
Lux
Part No
00G-4732-E0
Phase Name
Amylose-1
Elution Type
Isocratic
Mobile Phase
A: CO2/(Methanol + 0.5% IPA) 90:10 (v/v)
Gradient Profile
Step No.
Time(min)
%A
%B
1
0
100
0
Flow Rate
3.00 mL/min
Temperature
30°C
Detection
UV-Vis Abs.-Diode Array (PDA) @ (30°C)
Detection Info
Sample Notes
Courtesy of Tanika Van Mulders, Debby Mangelings and Yvan Vander Heyden, Department of Analytical Chemistry and Pharmaceutical Technology, Vrije Universiteit Brussel, Brussels, Belgium. Results of this analysis yielded: Alpha >1.1 and Resolution >2
Order Items Used in This Application
- 1. Flurbiprofen
- 2. Flurbiprofen
-OEChem-06211003152D<br><br> 31 32 0 1 0 0 0 0 0999 V2000<br> 2.0000 0.9050 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.5981 -3.5950 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0<br> 5.4641 -2.0950 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.7320 -2.0950 0.0000 C 0 0 3 0 0 0 0 0 0 0 0 0<br> 3.7320 -1.0950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.7320 0.9050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.8660 -0.5950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.5981 -0.5950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.8660 0.4050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.5981 0.4050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.8660 -2.5950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.7320 1.9050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.5981 -2.5950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.5981 2.4050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.8660 2.4050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.5981 3.4050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.8660 3.4050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.7320 3.9050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.7320 -2.9450 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.3291 -0.9050 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 5.1350 -0.9050 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 5.1350 0.7150 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.5560 -2.0581 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.3291 -2.9050 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.1760 -3.1319 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 5.1350 2.0950 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.3291 2.0950 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 5.1350 3.7150 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.3291 3.7150 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.7320 4.5250 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 5.1350 -3.9050 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 1 9 1 0 0 0 0<br> 2 13 1 0 0 0 0<br> 2 31 1 0 0 0 0<br> 3 13 2 0 0 0 0<br> 4 5 1 0 0 0 0<br> 4 11 1 0 0 0 0<br> 4 13 1 0 0 0 0<br> 4 19 1 0 0 0 0<br> 5 7 2 0 0 0 0<br> 5 8 1 0 0 0 0<br> 6 9 2 0 0 0 0<br> 6 10 1 0 0 0 0<br> 6 12 1 0 0 0 0<br> 7 9 1 0 0 0 0<br> 7 20 1 0 0 0 0<br> 8 10 2 0 0 0 0<br> 8 21 1 0 0 0 0<br> 10 22 1 0 0 0 0<br> 11 23 1 0 0 0 0<br> 11 24 1 0 0 0 0<br> 11 25 1 0 0 0 0<br> 12 14 2 0 0 0 0<br> 12 15 1 0 0 0 0<br> 14 16 1 0 0 0 0<br> 14 26 1 0 0 0 0<br> 15 17 2 0 0 0 0<br> 15 27 1 0 0 0 0<br> 16 18 2 0 0 0 0<br> 16 28 1 0 0 0 0<br> 17 18 1 0 0 0 0<br> 17 29 1 0 0 0 0<br> 18 30 1 0 0 0 0<br>M END
Compound Name
Flurbiprofen
CID
3394
Molecular Formula
C15H13FO2
Molecular Weight
244
No. Hydrogen Bond Acceptors
3
No. Hydrogen Bond Donors
1
Similar Applications
Reversed Phase
Verification of proposed USP-NF Flurbiprofen sodium Assay and Organic Impurities Monograph and subsequent Modernization under Allowable Adjustments_ Six Standard (RS) on Kinetex C18, 2.6 µm 150x3mm
Kinetex 2.6 µm C18 100 Å, LC Column 150 x 3 mm, Ea
28579
Reversed Phase
Verification of proposed USP-NF Flurbiprofen sodium Assay and Organic Impurities Monograph and subsequent Modernization under Allowable Adjustments_ Standard (RS) on Kinetex C18, 2.6 µm 150x3mm
Kinetex 2.6 µm C18 100 Å, LC Column 150 x 3 mm, Ea
28578
Reversed Phase
Verification of proposed USP-NF Flurbiprofen sodium Assay and Organic Impurities Monograph and subsequent Modernization under Allowable Adjustments_ SST on Kinetex C18, 2.6 µm 150x3mm
Kinetex 2.6 µm C18 100 Å, LC Column 150 x 3 mm, Ea
28577
Reversed Phase
Verification of proposed USP-NF Flurbiprofen sodium Assay and Organic Impurities Monograph and subsequent Modernization under Allowable Adjustments_ Sensitivity on Kinetex C18, 2.6 µm 150x3mm
Kinetex 2.6 µm C18 100 Å, LC Column 150 x 3 mm, Ea
28576
Reversed Phase
Verification of proposed USP-NF Flurbiprofen sodium Assay and Organic Impurities Monograph and subsequent Modernization under Allowable Adjustments_ Five Standard on Kinetex C18, 2.6 µm 150x3 mm
Kinetex 2.6 µm C18 100 Å, LC Column 150 x 3 mm, Ea
28575
Reversed Phase
Verification of proposed USP-NF Flurbiprofen sodium Assay and Organic Impurities Monograph and subsequent Modernization under Allowable Adjustments_Standard solution on Kinetex C18, 2.6 µm 150x3 mm
Kinetex 2.6 µm C18 100 Å, LC Column 150 x 3 mm, Ea
28574
Reversed Phase
Verification of proposed USP-NF Flurbiprofen sodium Assay and Organic Impurities Monograph and subsequent Modernization under Allowable Adjustments_ Six Standard (RS) on Kinetex C18, 5 µm 250x4.6mm
Kinetex 5 µm C18 100 Å, LC Column 250 x 4.6 mm, Ea
28573
Reversed Phase
Verification of proposed USP-NF Flurbiprofen sodium Assay and Organic Impurities Monograph and subsequent Modernization under Allowable Adjustments_ Standard (RS) on Kinetex C18, 5 µm 250x4.6mm
Kinetex 5 µm C18 100 Å, LC Column 250 x 4.6 mm, Ea
28572
Reversed Phase
Verification of proposed USP-NF Flurbiprofen sodium Assay and Organic Impurities Monograph and subsequent Modernization under Allowable Adjustments_ SST on Kinetex C18, 5 µm 250x4.6mm
Kinetex 5 µm C18 100 Å, LC Column 250 x 4.6 mm, Ea
28571
Reversed Phase
Verification of proposed USP-NF Flurbiprofen sodium Assay and Organic Impurities Monograph and subsequent Modernization under Allowable Adjustments_ Sensitivity on Kinetex C18, 5 µm 250x4.6mm
Kinetex 5 µm C18 100 Å, LC Column 250 x 4.6 mm, Ea
28570
Reversed Phase
Verification of proposed USP-NF Flurbiprofen sodium Assay and Organic Impurities Monograph and subsequent Modernization under Allowable Adjustments_ Five Standard on Kinetex C18, 5 µm 250x4.6mm
Kinetex 5 µm C18 100 Å, LC Column 250 x 4.6 mm, Ea
28569
Reversed Phase
Verification of proposed USP-NF Flurbiprofen sodium Assay and Organic Impurities Monograph and subsequent Modernization under Allowable Adjustments_Standard solution on Kinetex C18, 5 µm 250x4.6mm
Kinetex 5 µm C18 100 Å, LC Column 250 x 4.6 mm, Ea
28568
Reversed Phase
Verification of proposed USP-NF Flurbiprofen sodium Assay and Organic Impurities Monograph and subsequent Modernization under Allowable Adjustments_ Six Standard (RS) on Luna Omega C18, 5 µm 250x4.6mm
Luna Omega 5 µm C18 100 Å, LC Column 250 x 4.6 mm, Ea
28556
Reversed Phase
Verification of proposed USP-NF Flurbiprofen sodium Assay and Organic Impurities Monograph and subsequent Modernization under Allowable Adjustments_ Standard (RS) on Luna Omega C18, 5 µm 250x4.6mm
Luna Omega 5 µm C18 100 Å, LC Column 250 x 4.6 mm, Ea
28555
Reversed Phase
Verification of proposed USP-NF Flurbiprofen sodium Assay and Organic Impurities Monograph and subsequent Modernization under Allowable Adjustments_ SST on Luna Omega C18, 5 µm 250x4.6mm
Luna Omega 5 µm C18 100 Å, LC Column 250 x 4.6 mm, Ea
28554
Reversed Phase
Verification of proposed USP-NF Flurbiprofen sodium Assay and Organic Impurities Monograph and subsequent Modernization under Allowable Adjustments_ Sensitivity on Luna Omega C18, 5 µm 250x4.6mm
Luna Omega 5 µm C18 100 Å, LC Column 250 x 4.6 mm, Ea
28553
Reversed Phase
Verification of proposed USP-NF Flurbiprofen sodium Assay and Organic Impurities Monograph and subsequent Modernization under Allowable Adjustments_ Five Standard on Luna Omega C18, 5 µm 250x4.6mm
Luna Omega 5 µm C18 100 Å, LC Column 250 x 4.6 mm, Ea
28552
Reversed Phase
Verification of proposed USP-NF Flurbiprofen sodium Assay and Organic Impurities Monograph and subsequent Modernization under Allowable Adjustments_Standard solution on Luna Omega C18, 5 µm 250x4.6mm
Luna Omega 5 µm C18 100 Å, LC Column 250 x 4.6 mm, Ea
28551
Chiral
Lux i-Amylose-3 Separation for Flurbiprofen
Lux 5 µm i-Amylose-3, LC Column 250 x 4.6 mm, Ea
25352
Chiral
Lux i-Amylose-3 Separation for Flurbiprofen
Lux 5 µm i-Amylose-3, LC Column 250 x 4.6 mm, Ea
25346
Chiral
Flurbiprofen on Lux 5µm Amylose-1 by SFC
Lux 5 µm Amylose-1, LC Column 250 x 4.6 mm, EA
23298
Chiral
Flurbiprofen on Lux 5µm Amylose-1 by SFC
Lux 5 µm Amylose-1, LC Column 250 x 4.6 mm, EA
23285
Chiral
Flurbiprofen on LUX Amylose-1 5u in RP
Lux 5 µm Amylose-1, LC Column 250 x 4.6 mm, EA
23206
Flurbiprofen on Lux 5µm Amylose-2 by SFC
21139
Flurbiprofen on Lux 5µm Amylose-2 by SFC
21138
Flurbiprofen on Lux 5µm Amylose-2 by SFC
21137
Flurbiprofen on Lux 5µm Amylose-2 by SFC
21136
Flurbiprofen on Lux 5µm Amylose-2 by SFC
21135
Flurbiprofen on Lux 5µm Amylose-2 by SFC
21134
Chiral
Flurbiprofen on Lux Cellulose-3 with Acetonitrile
Lux 5 µm Cellulose-3, LC Column 250 x 4.6 mm, Ea
19356
Flurbiprofen on Lux Amylose-2 with Acetonitrile
19353
Effect of Acidic Additives on the RP Enantioseparation of Flurbiprofen on Lux Amylose-2
19327
NSAIDs on Onyx C18 (Luna Comparison)
15649
Reversed Phase
Fluoropharmaceuticals using Synergi Fusion-RP
Synergi 4 µm Fusion-RP 80 Å, LC Column 150 x 4.6 mm, Ea
14846
Reversed Phase
Nonsteroidal Anti-inflammatory
Luna 5 µm C18 100 Å, LC Column 100 x 4.6 mm, Ea
1179